Market capitalization | CHF3.71b |
Enterprise Value | CHF4.54b |
P/E (TTM) P/E ratio | 20.95 |
EV/FCF (TTM) EV/FCF | 20.83 |
EV/Sales (TTM) EV/Sales | 1.20 |
P/S ratio (TTM) P/S ratio | 0.98 |
P/B ratio (TTM) P/B ratio | 2.64 |
Dividend yield | 2.96% |
Last dividend (FY23) | CHF2.20 |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
6 Analysts have issued a Galenica forecast:
6 Analysts have issued a Galenica forecast:
Jun '24 |
+/-
%
|
||
Revenue | 3,795 3,795 |
3%
3%
|
|
Gross Profit | 381 381 |
3%
3%
|
|
EBITDA | 308 308 |
6%
6%
|
EBIT (Operating Income) EBIT | 203 203 |
8%
8%
|
Net Profit | 177 177 |
34%
34%
|
In millions CHF.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Galenica AG engages as a health care provider in Switzerland. It operates through the following segments: Health & Beauty and Services. The Health and Beauty segment comprises the two business sectors Retail; and Products and Brands. The Services segment offers pharmaceutical and healthcare companies pre-wholesale services, from storage and distribution of products in Switzerland to debt collection. The company was founded on 1927 and is headquartered in Bern, Switzerland.
Head office | Switzerland |
CEO | Marc Werner |
Employees | 5,907 |
Founded | 1927 |
Website | www.galenica.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.